CORYNEX™ Licensing & Transfer
Access CORYNEX™ through a flexible licensing and technology transfer model, with qualified partner CDMOs trained on the platform and technical support from our specialists.
Continuity from Development to GMP
From strain development through commercial GMP supply, the CORYNEX™ model is designed to support process continuity through technology transfer and ongoing technical support.
From Development to GMP
We develop the CORYNEX™ process and lead technology transfer to qualified partner CDMOs, providing technical support as the process moves into GMP manufacturing.
Our Track Record
CORYNEX™ has supported programs that have progressed through FDA review to Phase II clinical trials. Our team also provides process documentation and technical input to support IND CMC requirements.
Qualified GMP Manufacturing Partners
For GMP manufacturing, CORYNEX™ processes are transferred to qualified partner CDMOs, including Richter BioLogics and Olon S.p.A., with our team providing technical support through technology transfer and process implementation.
Integrating CORYNEX™ with Your Therapy
Licensing CORYNEX™ is a structured integration — not just a document transfer. Our technical team works alongside licensees from strain selection through the first successful GMP batch.
Licensing Models
Flexible licensing models support CORYNEX™ programs from early evaluation through clinical and commercial manufacturing.
Early Development
Access to CORYNEX™ technology for feasibility evaluation with a target protein or peptide
Strain access defined by molecule type and evaluation scale
Technical support from our experts throughout the evaluation
Pathway to a commercial license as the program advances
Commercial
Complete technology transfer package, including strain and process documentation
CORYNEX™ process rights for GMP clinical and commercial manufacturing
Regulatory documentation to support IND/BLA CMC filings
Ongoing technical support and access to process optimization expertise
Let’s Discuss CORYNEX™
Licensing for Your Program
Frequently Asked Questions
What licensing models are available for CORYNEX™?
With the standard licensing model for CORYNEX™, Ajinomoto Bio-Pharma Services manages development through manufacturing, including subcontracting to partner CDMOs. Alternatively, Aji Bio-Pharma also offers a technology licensing model where the strain and process are developed before licensing to the client and/or the client’s preferred CDMOs.
Can I use CORYNEX™ at my own CDMO?
Yes. Technology licensing and tech transfer packages are available to enable the use of CORYNEX™ at the client’s own or preferred third-party CDMO facilities. Ajinomoto Bio-Pharma Services will provide the necessary strains, process documentation, training, and technical support.
What does CORYNEX™ tech transfer include?
CORYNEX™ technology transfer includes the custom-engineered strain, USP, DSP, and analytics. Full process documentation, training for the receiving site’s team, and ongoing technical support from the Ajinomoto Bio-Pharma Services team are also included.